This post was contributed by a community member. The views expressed here are the author's own.

Health & Fitness

MelroseWakefield Hospital performs first drug-coated balloon procedure

New Drug-coated balloons effectively treat in-stent restenosis

The MelroseWakefield Hospital Cardiovascular Center completed another important "first" last week, when they used a drug-coated balloon while treating a patient with coronary artery disease. Dr. Laurence Conway, Chief of Cardiology, performed the procedure.

Manufactured by Boston Scientific, the AGENT™ Drug-Coated Balloon (DCB) is the first FDA-approved drug-coated coronary balloon in the U.S. for the treatment of coronary in-stent restenosis.

In-stent restenosis (ISR) occurs when a previously stented artery becomes re-narrowed or blocked by scar tissue or plaque. transfers a therapeutic dose of paclitaxel to the coronary artery wall to help prevent ISR reoccurrence.

Find out what's happening in Melrosefor free with the latest updates from Patch.

The views expressed in this post are the author's own. Want to post on Patch?